A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Yanagawa, Hiroyuki ^a   Suzuki, Hitoshi ^a   Suzuki, Yusuke ^a   Kiryluk, Krzysztof ^b   Gharavi, Ali G ^b   Matsuoka, Kiyoshi ^a   Makita, Yuko ^a   Julian, Bruce A ^c,d   Novak, Jan ^d   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c and Clinical Center   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GALACTOSE IMMUNOGLOBULIN A1 ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; GALACTOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ACUTE POST STREPTOCOCCAL NEPHRITIS; ADULT; ANCA RELATED NEPHRITIS; ANTIBODY SPECIFICITY; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FABRY DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HCV RELATED NEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE MEDIATED KIDNEY DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSCLEROSIS; NEPHROTIC SYNDROME; NON IMMUNOGLOBULIN A PROLIFERATIVE NEPHROPATHY; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PROGNOSIS; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SCLERODERMA RENAL CRISIS; SENSITIVITY AND SPECIFICITY; TREND STUDY; BLOOD; DIFFERENTIAL DIAGNOSIS; GLOMERULONEPHRITIS, IGA; METABOLISM; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALACTOSE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED;

EID: 84901462125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098081     Document Type: Article

References (34)

1. D'Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727.
2. Julian BA, Waldo FB, Rifai A, Mestecky J (1988) IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 84: 129-132.
3. D'Amico G (2000) Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36: 227-237.
4. Russell MW, Mestecky J, Julian BA, Galla JH (1986) IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J Clin Immunol 6: 74-86. (Pubitemid 16128512)
5. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, et al. (1993) Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104: 172-182.
6. Allen AC, Harper SJ, Feehally J (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100: 470-474.
7. Novak J, Julian BA, Tomana M, Mestecky J (2008) IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 28: 78-87.
8. Hiki Y, Horii A, Iwase H, Tanaka A, Toda Y, et al. (1995) O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. Contrib Nephrol 111: 73-84.
9. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, et al. (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71: 1148-1154. (Pubitemid 46809135)
10. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, et al. (2001) Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59: 1077-1085. (Pubitemid 32206870)
11. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, et al. (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O -glycosylation: observations in three patients. Kidney Int 60: 969-973. (Pubitemid 34205796)
12. Czerkinsky C, Koopman WJ, Jackson S, Collins JE, Crago SS, et al. (1986) Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 77: 1931-1938. (Pubitemid 16062650)
13. Coppo R, Basolo B, Piccoli G, Mazzucco G, Bulzomì MR, et al. (1984) IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol 57: 583-590. (Pubitemid 14057714)
14. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, et al. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52: 509-516. (Pubitemid 27359597)
15. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, et al. (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81. (Pubitemid 29534347)
16. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, et al. (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1668-1677.
17. Tomino Y, Sakai H (2003) Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease: Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 7: 93-97.
18. Moore JS, Kulhavy R, Tomana M, Moldoveanu Z, Suzuki H, et al. (2007) Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol 44: 2598-2604. (Pubitemid 46240321)
19. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, et al. (2008) IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118: 629-639. (Pubitemid 351206552)
20. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19: 716-723.
21. van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, et al. (2004) An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. Nephrol Dial Transplant 19: 2487-2493. (Pubitemid 39360093)
22. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, et al. (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22: 1795-1803.
23. Coppo R, Amore A (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65: 1544-1547. (Pubitemid 38590997)
24. Barratt J, Feehally J (2005) IgA nephropathy. J Am Soc Nephrol 16: 2088-2097. (Pubitemid 41716440)
25. Julian BA, Novak J (2004) IgA nephropathy: an update. Curr Opin Nephrol Hypertens 13: 171-179. (Pubitemid 38373139)
26. Novak J, Julian BA, Tomana M, Mesteck J (2001) Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 21: 310-327. (Pubitemid 33015802)
27. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, et al. (2002) Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 62: 465-475. (Pubitemid 34779757)
28. Novak J, Tomana M, Matousovic K, Brown R, Hall S, et al. (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513. (Pubitemid 40139842)
29. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, et al. (2008) Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294: F945-955.
30. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, et al. (2009) Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24: 62-72.
31. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, et al. (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19: 1008-1014.
32. Takahashi K, Wall SB, Suzuki H, Smith AD 4th, Hall S, et al. (2010) Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics 9: 2545-2557.
33. Zhang J, Jacobi AM, Wang T, Berlin R, Volpe BT, et al. (2009) Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun 33: 270-274.
34. Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, et al. (2008) Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA 105: 9727-9732. (Pubitemid 352031368)